SMTL ID : 5mkv.1

Crystal Structure of Human Dihydropyrimidinease-like 2 (DPYSL2A)/Collapsin Response Mediator Protein (CRMP2) residues 13-516

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.80 Å

Oligo State

homo-tetramer

Ligands

22 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)

EDO.1: 8 residues within 4Å: Chain A: R.63, K.242, T.291, A.320, C.322, E.341, G.342 Ligands: EDO.6 Ligand excluded by PLIP EDO.2: 5 residues within 4Å: Chain A: N.414, L.442, G.445, L.447 Ligands: EDO.3 Ligand excluded by PLIP EDO.3: 4 residues within 4Å: Chain A: A.86, E.347, T.412 Ligands: EDO.2 Ligand excluded by PLIP EDO.4: 7 residues within 4Å: Chain A: V.97, P.98, E.99, T.102, A.107, Q.110, W.111 Ligand excluded by PLIP EDO.5: 7 residues within 4Å: Chain A: R.256, G.259, T.260, R.469 Chain B: S.310, C.311 Ligands: EDO.7 Ligand excluded by PLIP EDO.6: 9 residues within 4Å: Chain A: I.267, T.291, S.319, A.320, C.322, G.342, T.343, N.344 Ligands: EDO.1 Ligand excluded by PLIP EDO.7: 6 residues within 4Å: Chain A: R.256, Y.263, Q.315, F.465, R.469 Ligands: EDO.5 Ligand excluded by PLIP EDO.8: 6 residues within 4Å: Chain A: W.283, K.333 Chain C: R.484, G.485, L.486, Y.487 Ligand excluded by PLIP EDO.9: 2 residues within 4Å: Chain A: K.333 Chain C: Y.487 Ligand excluded by PLIP EDO.10: 6 residues within 4Å: Chain A: D.15, D.364, N.366, Q.367, A.370 Chain B: F.465 Ligand excluded by PLIP EDO.11: 5 residues within 4Å: Chain A: D.464, K.468 Chain B: K.11, S.18, E.365 Ligand excluded by PLIP EDO.12: 0 residues within 4Å: (No contacts) Ligand excluded by PLIP EDO.13: 5 residues within 4Å: Chain A: K.11, S.18, E.365 Chain B: D.464, K.468 Ligand excluded by PLIP EDO.14: 6 residues within 4Å: Chain B: R.256, V.261, V.262, Y.263, Q.315, R.469 Ligand excluded by PLIP EDO.15: 9 residues within 4Å: Chain B: A.83, H.321, N.344, E.347, E.348, H.413, N.414, S.415, N.420 Ligand excluded by PLIP EDO.16: 6 residues within 4Å: Chain C: R.256, G.259, T.260, R.469 Chain D: S.310, C.311 Ligand excluded by PLIP EDO.17: 0 residues within 4Å: (No contacts) Ligand excluded by PLIP EDO.18: 5 residues within 4Å: Chain D: N.14, F.19, I.33, I.389, A.390 Ligand excluded by PLIP EDO.19: 4 residues within 4Å: Chain D: D.15, N.366, Q.367, A.370 Ligand excluded by PLIP EDO.20: 5 residues within 4Å: Chain D: K.11, M.52, W.354, E.365, P.402 Ligand excluded by PLIP EDO.21: 4 residues within 4Å: Chain D: N.414, L.442, G.445, L.447 Ligand excluded by PLIP EDO.22: 7 residues within 4Å: Chain D: A.83, H.321, N.344, E.347, E.348, H.413, N.420 Ligand excluded by PLIP

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Zheng, Y. et al., Tuning microtubule dynamics to enhance cancer therapy by modulating FER-mediated CRMP2 phosphorylation. Nat Commun (2018)

Release Date

2017-02-22

Peptides

Dihydropyrimidinase-related protein 2: ABCD

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
C

D
D

Dihydropyrimidinase-related protein 2